WO2025062425 - AN ORAL SOLID PHARMACEUTICAL FORMULATION OF ENZALUTAMIDE

National phase entry is expected:
Publication Number WO/2025/062425
Publication Date 27.03.2025
International Application No. PCT/IN2024/051781
International Filing Date 18.09.2024
Title [English] AN ORAL SOLID PHARMACEUTICAL FORMULATION OF ENZALUTAMIDE [French] FORMULATION PHARMACEUTIQUE SOLIDE ORALE D'ENZALUTAMIDE
Applicants ** BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED 407-408, SHARDA CHAMBERS, NEW MARINE LINES, MUMBAI, MAHARASHTRA, INDIA. MUMBAI 400020, IN
Inventors ** SHAH, Dharmesh Mahendrabhai BDR PHARMACEUTICAL INTERNATIONAL PVT. LTD.; “ENGINEERING CENTRE”, 6TH FLOOR, 9, MATHEW ROAD, OPERA HOUSE, MUMBAI, MAHARASHTRA MUMBAI 400004, IN BADIGER, Aravind Manappa BDR RESEARCH CENTRE; BDR PHARMACEUTICALS INTERNATIONAL PVT. LTD.; SURVEY NO. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: VANSETI VILLAGE, PO: TAJPURA, TALUKA: HALOL, DISTRICT: PANCHMAHALS GUJARAT 389350, IN UPADHYE, Abhijeet Ashokrao BDR RESEARCH CENTRE; BDR PHARMACEUTICALS INTERNATIONAL PVT. LTD.; SURVEY NO. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: VANSETI VILLAGE, PO: TAJPURA, TALUKA: HALOL, DISTRICT: PANCHMAHALS GUJARAT 389350, IN PANCHAL, Samir Babulal BDR RESEARCH CENTRE; BDR PHARMACEUTICALS INTERNATIONAL PVT. LTD.; SURVEY NO. 51/1,51/1/2,51/2,52/2/1,52/2,54/2; AT: VANSETI VILLAGE, PO: TAJPURA, TALUKA: HALOL, DISTRICT: PANCHMAHALS GUJARAT 389350, IN
Priority Data 202321062597  18.09.2023  IN
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 924
EPO Filing, Examination 6434
Japan Filing 554
South Korea Filing 577
USA Filing, Examination 2635
+ Add country
MasterCard Visa
Total: 11124
QUOTE TO EMAIL ONLINE QUOTE
Abstract [English] The present invention relates to novel oral solid pharmaceutical formulation of enzalutamide or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient. An enzalutamide pharmaceutical formulation comprising a one or more pharmaceutically acceptable polymers is provided by the present invention. In addition, the present invention also provides an improved process for preparation of enzalutamide oral solid pharmaceutical formulation. [French] La présente invention concerne une nouvelle formulation pharmaceutique solide orale d'enzalutamide ou d'un sel pharmaceutiquement acceptable de celui-ci et un ou plusieurs excipients pharmaceutiquement acceptables. La présente invention concerne une formulation pharmaceutique d'enzalutamide comprenant un ou plusieurs polymères pharmaceutiquement acceptables. De plus, la présente invention concerne également un procédé amélioré de préparation d'une formulation pharmaceutique solide orale d'enzalutamide.